Giuseppe Caruso
@gcarusomd
Followers
242
Following
579
Statuses
162
MD @Unicatt - Gynecologic Oncologist @IEOufficiale - PhD Fellow in Oncology @SapienzaRoma - Research Collaborator/Former Research Fellow @MayoClinic
Roma, Lazio
Joined May 2021
RT @ValenzaCarmine: 📣 Just out our last paper on platinum rechallenge in pts with PROC in @gynoncjnls ⚠️ Platinum-free interval is not ad…
0
10
0
RT @gynoncjnls: Incorporating immune checkpoint inhibitors in epithelial ovarian cancer @SGO_org @IGCSociety @ESGO_society @OncoAlert https…
0
5
0
Check out this insightful review 📚📢 Incorporating immune checkpoint inhibitors in epithelial ovarian cancer - Gynecologic Oncology @BoganiGiorgio @DrKatyMoore @CoquardRay @PrJEKurtz @SGO_org
0
4
13
✨ 2024: A Breakthrough Year in Gynecologic Oncology! ✨ With 6 new FDA-approved drugs/indications, we're entering a brighter future for patients battling gynecological malignancies. Hope is stronger than ever! 💪
1
34
80
Is IO in OC really a closed case? 🤔 Beyond DUO-O showing improved PFS with Bev-durv-ola vs Bev in tBRCAwt, two recent announcements: 1⃣ FIRST: Improved PFS with Bev-Dostar-Nirap vs Bev-Nirap. 2⃣ KEYLINK-001: Improved PFS with Bev-Pembro-Ola vs Bev in tBRCAwt. Stay tuned!
0
0
8
@leitaomd I totally agree, Professor. We included surgery as an option for IB3/IIA. We tried to capture all the options currently available, especially taking into account low-resource countries.
0
1
7
If you missed this, it is NOW FREE! You can download it! All you need to know about cervical cancer with latest updates. Such an amazing teamwork! 💯🔝 @IJGConline @IJGCfellows @ESGO_society @ENYGO_official @OncoAlert @pedroramirezMD @HsuMd
#CervicalCancer: a new era Depending on stage, histology, and patient factors, the standard management of #cervicalcancer is a combination of treatment approaches 👀 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @Jc_vilches @erodriguezglez @daggezmine @astraubhar @raikhanbo @gcarusomd @mattkwagar @oncohoegl @guidoreyv @Cucinella_G @seda2211 @RParejaGineOnco @Jessica_mauro3
0
7
22
RT @IJGConline: #CervicalCancer: a new era Depending on stage, histology, and patient factors, the standard management of #cervicalcancer…
0
20
0
The 15th ENGOT GCA workshop in Stresa 🇮🇹 Feeling so grateful for this great experience and the chance to learn from KOLs and meet amazing young colleagues! @ESGO_society @EngageEsgo @ENYGO_official
1
2
15
@IJGConline @HsuMd @pedroramirezMD @JayrajAarthi @AndreFernandes2 @IGCSociety So well deserved! Congratulations @HsuMd
2
0
4
RT @IJGConline: 🎉 Congratulations on receiving the #IJGC Top Reviewer Award! Thank you for setting the standard of excellence! 👏🤩 #TopRevi…
0
11
0
So excited and honored to receive the 2024 IJGC Top Reviewer Award! Such a great Team! @IJGConline @IJGCfellows @IGCSociety @ESGO_society @pedroramirezMD
0
0
26
RT @glaucobaiocchi: @IJGConline Editorial Board meeting at #IGCS2024. Proud to be part of this amazing team! @pedroramirezMD
@IGCSociety @a…
0
5
0
RT @IJGConline: Impact of #molecularclassification on recurrence risk in #endometrialcancer patients with lymph node metastasis ⭐ https://…
0
13
0
Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial - The Lancet
0
0
12
Proud of this amazing teamwork with my Mentor Prof. Cliby @MayoClinic @MayoGynecology @MayoObGynResFel @IEOufficiale @MayoMrfa @IGCSociety @SGO_org @ESGO_society
Textbook📕oncologic outcome is an easy-to-use ✅ composite quality measure that is strongly associated with survival 📊 in advanced-stage ovarian cancer @MayoGynecology @SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert
0
1
13
Textbook oncologic outcome (TOO) is an easy-to-use composite quality measure that is strongly associated with survival in advanced-stage ovarian cancer @gynoncjnls @SGO_org @IGCSociety @ESGO_society @OncoAlert
2
2
12
RT @ESGO_society: For your weekend reading 🗞️: results of primary PFS in the AtTEnd trial, an ENGOT academic study sponsored by MaNGO, were…
0
3
0
RT @ESGO_society: The ESGO - @ESTRO_RT - @ESP_Pathology Endometrial cancer guidelines update working group held a hybrid meeting in Vienna…
0
7
0